AIDS 2022

29 Jul - 2 Aug 2022
Montreal, Canada & virtually

Registration is open

It’s time to re-engage and follow the science. Take part in the world’s largest gathering on HIV and AIDS.

AIDS 2022, the 24th International AIDS Conference, will call on the world to come together to re-engage and follow the science. It will define future research agendas, shift latest evidence to action, and chart a new consensus on overcoming the HIV epidemic as a threat to public health and individual well-being.

Satellite Session| Strengthening health systems for holistic HIV prevention, cervical cancer and female genital schistosomiasis prevention and control services

Frontline AIDS, WHO, UNAIDS | room 517b/Channel 4 | 02 August 08:00 - 09:00


  • Patriciah Jeckonia - Sr Technical Advisor, Policy and Partnerships, LVCT Health Kenya

Opening remarks

  • Marijke Wijnroks - Chief of Staff, The Global Fund to Fight AIDS, Tuberculosis and Malaria


  • Jutta Reinhard-Rupp (virtual) - Head of the Global Health Institute, Merck
  • Pamela Sabina Mbabazi - WHO, Department of Control of Neglected Tropical Diseases
  • Margaret Gyapong - Director of the Institute of Health Research (IHR) and Coordinator of the Centre for Health Policy and Implementation Research (CHPIR) at the University of Health and Allied Sciences (UHAS), Ghana
  • Naisiadet Mason - Director of Public Policy, Guttmacher Institute
  • Helena Nangombe - Young Women Empowerment Network, Namibia


This Satellite Session is dedicated to Dr Mwelecele Ntuli Malecela, Director of Neglected Tropical Diseases at the World Health Organization (WHO) - a passionate champion of women's health and rights and at the forefront of female genital schistosomiasis (FGS) cervical cancer and HIV integration. This event is the next in a series of High-Level political events calling for integration of HIV programming and services with sexual and reproductive health and rights (SRHR) issues, especially human papillomavirus (HPV), cervical cancer and female genital schistosomiasis (FGS) which is fundamental to the health and wellbeing of women and girls, in all their diversity.

Recognising that African girls and women bear a disproportionate global disease burden, facing multiple and intersecting health, social, cultural and economic challenges, the global health community is putting its weight behind a shared commitment to advance universal access to integrated health, SRHR and HIV services. The first of these sessions was held at AIDS 2018 in Amsterdam, the WHO/UNAIDS policy briefing on FGS integration was launched at ICASA 2019, a follow-on event was held at ICASA 2021 and AIDS 2022 is the next significant moment. The purpose of this satellite is to showcase the progress that has been made towards integrating HIV, cervical cancer and FGS, highlighting the policy wins within the SDGs, the 2016/2019/2021 High Level Political Declarations on Ending AIDS, Universal Health Coverage, WHO's Global Strategy to eliminate cervical cancer as a public health problem, and WHO's Ending the neglect to attain the sustainable development goals. One health: approach for action against neglected tropical diseases 2021-2030 and UNAIDS Global AIDS Strategy 2021-2026, provide strategic opportunities to break down the silos, unite agendas and translate these commitments into joint action, for women's health and progress.

The satellite will be a platform where women who have experienced SRHR issues, First Ladies, Donor Governments, WHO and UNAIDS Ambassadors can stand together to: - advocate and mobilise global, regional, national and community support, commitment and resourced action for the provision of integrated rights-based services for high quality HIV, cervical cancer and FGS prevention and control –putting the needs of most marginalized adolescent girls and young women at the centre; - expand, diversify and broaden collaboration and partnerships, including for resources, in support of cross-sector integrated rights-based SRHR, HIV, cervical cancer and FGS services; - increase the recognition and acknowledgement of FGS as a SRH condition and co-factor for HIV, HPV, other SRH ill-health outcomes; and - ensure civil society and communities' engagement and leadership in the design and implementation of quality and acceptable cross-sector integrated holistic healthcare for women and girls, in all their diversity.


Female Genital Schistosomiasis